Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies

被引：23

作者：

Ahmed, Yousuf ^{[1
]}

Tian, Meijuan ^{[1
]}

Gao, Yong ^{[1
]}

机构：

[1] Univ Western Ontario, Dept Microbiol & Immunol, Schulich Sch Med & Dent, London, ON, Canada

来源：

AIDS RESEARCH AND THERAPY | 2017年 / 14卷

关键词：

HIV-1; Diversity; Broadly neutralizing antibody; Polyvalent vaccine; B cell maturation; HUMAN-IMMUNODEFICIENCY-VIRUS; POTENT NEUTRALIZATION; ENVELOPE GLYCOPROTEIN; RHESUS-MONKEYS; SUBTYPE-B; INFECTION; RESPONSES; PROTECTION; SELECTION; IDENTIFICATION;

D O I：

10.1186/s12981-017-0178-3

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

The extreme HIV diversity posts a great challenge on development of an effective anti-HIV vaccine. To solve this problem, it is crucial to discover an appropriate immunogens and strategies that are able to prevent the transmission of the diverse viruses that are circulating in the world. Even though there have been a number of broadly neutralizing anti-HIV antibodies (bNAbs) been discovered in recent years, induction of such antibodies to date has only been observed in HIV-1 infection. Here, in this mini review, we review the progress in development of HIV vaccine in eliciting broad immune response, especially production of bNAbs, discuss possible strategies, such as polyvalent sequential vaccination, that facilitates B cell maturation leading to bNAb response.

引用

页数：6

共 50 条

[1] Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
Yousuf Ahmed
Meijuan Tian
Yong Gao
[J]. AIDS Research and Therapy, 14
[2] Difficulties in eliciting broadly neutralizing anti-HIV antibodies are not explained by cardiolipin autoreactivity
Scherer, Erin M.
Zwick, Michael B.
Teyton, Luc
Burton, Dennis R.
[J]. AIDS, 2007, 21 (16) : 2131 - 2139
[3] Opening Fronts in HIV Vaccine Development: Tracking the development of broadly neutralizing antibodies
Henning Gruell
Florian Klein
[J]. Nature Medicine, 2014, 20 : 478 - 479
[4] Vaccine Constructs with Resurfaced gp120: A Step towards an HIV Vaccine Eliciting Broadly Neutralizing Antibodies?
Kabashi, Saranda
Oynebraten, Inger
Bogen, Bjarne
[J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2011, 73 (04) : 389 - 389
[5] Broadly Neutralizing Anti-HIV Antibodies Prevent HIV Infection of Mucosal Tissue Ex Vivo
Scott, Yanille M.
Park, Seo Young
Dezzutti, Charlene S.
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (02) : 904 - 912
[6] Targeted Sequencing of Broadly Neutralizing Anti-HIV Envelope Antibodies Directly from Plasma
Sajadi, Mohammad
[J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2016, 71 : 91 - 91
[7] Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design
Burton, Dennis R.
Hangartner, Lars
[J]. ANNUAL REVIEW OF IMMUNOLOGY, VOL 34, 2016, 34 : 635 - 659
[8] Strategies for eliciting multiple lineages of broadly neutralizing antibodies to HIV by vaccination
Mu, Zekun
Haynes, Barton F.
Cain, Derek W.
[J]. CURRENT OPINION IN VIROLOGY, 2021, 51 : 172 - 178
[9] HIV Sequential vaccine elicits broadly neutralizing antibodies
Flemming, Alexandra
[J]. NATURE REVIEWS DRUG DISCOVERY, 2016, 15 (11) : 749 - 749
[10] Recent progress in anti-HIV broadly neutralizing antibody research
Tobin, Stacey C.
[J]. AIDS, 2017, 31 (16) : N21 - N21

← 1 2 3 4 5 →